Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

SIMPLE SUMMARY: Although the clinical trial of atezolizumab plus bevacizumab have revealed its efficacy for HCC, the outcomes in the real-world clinical practice are unclear. In the study, we retorspectively evaluated the efficacy and safety of atezoizumab plus bevacizumab for HCC. Atezorizumab plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Hideki, Shimose, Shigeo, Noda, Yu, Shirono, Tomotake, Niizeki, Takashi, Nakano, Masahito, Okamura, Shusuke, Kamachi, Naoki, Suzuki, Hiroyuki, Sakai, Miwa, Kajiwara, Akira, Itano, Satoshi, Tanaka, Masatoshi, Yamaguchi, Taizo, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199943/
https://www.ncbi.nlm.nih.gov/pubmed/34205099
http://dx.doi.org/10.3390/cancers13112786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199943/
https://www.ncbi.nlm.nih.gov/pubmed/34205099
http://dx.doi.org/10.3390/cancers13112786

Ejemplares similares